Literature DB >> 15769209

Metacognition and false recognition in Alzheimer's disease: further exploration of the distinctiveness heuristic.

Andrew E Budson1, Chad S Dodson, Kirk R Daffner, Daniel L Schacter.   

Abstract

The distinctiveness heuristic is a response mode in which participants expect to remember vivid details of an experience and make recognition decisions on the basis of this metacognitive expectation. The authors examined whether the distinctiveness heuristic could be engaged to reduce false recognition in a repetition-lag paradigm in patients with Alzheimer's disease (AD). Patients with AD were able to use the distinctiveness heuristic--though not selectively--and thus they showed reduction of both true and false recognition. The authors suggest that patients with AD can engage in decision strategies on the basis of the metacognitive expectation associated with use of the distinctiveness heuristic, but the patients' episodic memory impairment limits both the scope and effectiveness of such strategies. ((c) 2005 APA, all rights reserved).

Entities:  

Mesh:

Year:  2005        PMID: 15769209     DOI: 10.1037/0894-4105.19.2.253

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  22 in total

1.  Using mental imagery to improve memory in patients with Alzheimer disease: trouble generating or remembering the mind's eye?

Authors:  Erin P Hussey; John G Smolinsky; Irene Piryatinsky; Andrew E Budson; Brandon A Ally
Journal:  Alzheimer Dis Assoc Disord       Date:  2012 Apr-Jun       Impact factor: 2.703

2.  Alzheimer's disease can spare local metacognition despite global anosognosia: revisiting the confidence-accuracy relationship in episodic memory.

Authors:  David A Gallo; Stefanie J Cramer; Jessica T Wong; David A Bennett
Journal:  Neuropsychologia       Date:  2012-06-18       Impact factor: 3.139

3.  The worth of pictures: using high density event-related potentials to understand the memorial power of pictures and the dynamics of recognition memory.

Authors:  Brandon A Ally; Andrew E Budson
Journal:  Neuroimage       Date:  2007-01-03       Impact factor: 6.556

4.  Discrimination and reliance on conceptual fluency cues are inversely related in patients with mild Alzheimer's disease.

Authors:  David A Wolk; Carl A Gold; Eric D Signoff; Andrew E Budson
Journal:  Neuropsychologia       Date:  2009-03-04       Impact factor: 3.139

5.  Effects of distinctive encoding on source-based false recognition: further examination of recall-to-reject processes in aging and Alzheimer disease.

Authors:  Benton H Pierce; Jill D Waring; Daniel L Schacter; Andrew E Budson
Journal:  Cogn Behav Neurol       Date:  2008-09       Impact factor: 1.600

6.  Alzheimer's disease and memory-monitoring impairment: Alzheimer's patients show a monitoring deficit that is greater than their accuracy deficit.

Authors:  Chad S Dodson; Maggie Spaniol; Maureen K O'Connor; Rebecca G Deason; Brandon A Ally; Andrew E Budson
Journal:  Neuropsychologia       Date:  2011-05-19       Impact factor: 3.139

7.  Conceptual fluency at test shifts recognition response bias in Alzheimer's disease: implications for increased false recognition.

Authors:  Carl A Gold; Natalie L Marchant; Wilma Koutstaal; Daniel L Schacter; Andrew E Budson
Journal:  Neuropsychologia       Date:  2007-05-10       Impact factor: 3.139

8.  Preserved metamemorial ability in patients with mild Alzheimer's disease: shifting response bias.

Authors:  Jill D Waring; Hyemi Chong; David A Wolk; Andrew E Budson
Journal:  Brain Cogn       Date:  2007-06-18       Impact factor: 2.310

9.  The picture superiority effect in patients with Alzheimer's disease and mild cognitive impairment.

Authors:  Brandon A Ally; Carl A Gold; Andrew E Budson
Journal:  Neuropsychologia       Date:  2008-10-17       Impact factor: 3.139

10.  Ciproxifan, an H3 receptor antagonist, improves short-term recognition memory impaired by isoflurane anesthesia.

Authors:  Fang Ding; Limin Zheng; Min Liu; Rongfa Chen; L Stan Leung; Tao Luo
Journal:  J Anesth       Date:  2016-05-19       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.